THE world’s first Ebola vaccine was recommended for approval by European regulators yesterday.
The move was hailed by the World Health Organisation as a “triumph for public health” that would save many lives.
The vaccine, developed by US firm Merck & Co, is already being used under emergency guidelines to try to protect against the spread of Ebola in Democratic Republic of Congo.
The shot is also being reviewed under a fast-track system by regulators in the United States, with a decision expected in the first quarter of next year.
WHO’s director-general Tedros Adhanom Ghebreyesus said: “This vaccine has already saved many lives in the current Ebola outbreak, and the decision by European regulators will help it to eventually save many more.”
The Congo Ebola outbreak has killed more than 2,100 people since the middle of last year.
It is the second-largest Ebola outbreak in history, after a 2013-16 epidemic in West Africa that killed more than 11,300.
GOT a story? RING The Sun on 0207 782 4104 or WHATSAPP on 07423720250 or EMAIL exclusive@the-sun.co.uk